Plain-English translation of NCT06161207 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether combining 3D ultra-high-resolution imaging with indocyanine green tracer (a special dye that glows under near-infrared light) during laparoscopic (minimally invasive) stomach cancer surgery improves outcomes. Researchers want to see if this technology helps surgeons locate and remove lymph nodes more completely, which could prevent cancer from returning. The study will compare three surgical approaches to find out which works best for patients with locally advanced gastric cancer.
Standard stomach cancer surgery can miss small lymph nodes where cancer may have spread, which can lead to cancer recurrence. This new imaging technology is designed to help surgeons see and remove cancer more completely during minimally invasive surgery, potentially improving long-term survival and reducing the chance the cancer comes back.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive one of three types of minimally invasive stomach cancer surgery—all involving removal of the stomach and nearby lymph nodes, but using different levels of imaging technology. You will be admitted for surgery and recovery, then followed up regularly over three years with imaging tests and office visits to monitor whether your cancer returns and track your overall health. The study team will carefully document your surgical experience, recovery, and long-term outcomes.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
China
Phase
Large-scale testing
Sponsor
Fujian Medical University
Enrollment target
~702 participants
Started
January 2023
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mi Lin
Fujian Medical University Union Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.